Enzyme-linked Immunosorbent Assays were developed to the catecholamine
s adrenaline and noradrenaline which were capable of catecholamine det
ection to concentrations of 100pg/ml and 1ng/ml respectively. Cross-re
activity assays revealed that neither assay was subject to interferenc
e by the catecholamine metabolites and derivatives at concentrations b
elow 100ng/ml and 1mug/ml. Both ELISAs were validated against the rout
inely employed method of catecholamine estimation, high performance li
quid chromatography (HPLC). When this was used in combination with UV
spectrophotometry it is shown that both ELISAs offer a more sensitive
means of catecholamine detection with less intra and inter-assay varia
tion. The ELISAs are recommended as relatively simple and efficient me
thods of rapidly and routinely monitoring a large number of samples fo
r catecholamine quantification which can further be developed for clin
ical immunoassays for neural-crest tumour screening.